Insight that enriches. Precision that empowers.

We are advancing a novel class of targeted therapies that directly address the genetic alterations associated with selected tumors.

Learn More
 the man was staring into the distance
woman staring into the distance
 the man with beard staring into the distance

Our Science

Our powerful synthetic lethality-based approach to the development of new precision oncology therapeutics has multiple potential benefits.

Our Pipeline

We are leveraging our proprietary SNIPRx® platform to discover, validate and build a robust pipeline of synthetic lethality-based therapeutics.
doctor patient conversating

Our Clinical Trials

We are developing a portfolio of product candidates based on targets identified using our SNIPRx platform to treat cancers with a high unmet medical need.

Join our team and make a difference.